NASDAQ
Bellicum Pharmaceuticals, Inc. (BLCM) has a free cash flow growth of 81.03% as of Friday, May 29, 2026. This represents a 1457.34% increase compared to its 12-month average of -5.97%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.